Internal Medicine, Infectious Disease · Orlando, FL
NPI
1023338878
Since 2010
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1707 N Mills Ave
Orlando, FL, 32803
Phone (407) 647-3960
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,910
97 services
Medicare patients, 2024
48
Average age 64
Drug cost, 2024
$2.9M
1,053 prescriptions
Company payments, 2025
$113K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charlotte-Paige M Rolle was code 99214 (office e&m - established), 37 times for 25 patients. In total Charlotte-Paige M Rolle billed 97 services in 20 codes, and Medicare paid $7,910.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 37 | 25 | $92.27 | $3,414 |
| 99213 Office E&M - Established | Office | 20 | 18 | $60.74 | $1,215 |
By year: 2022 $13K for 241 services; 2023 $5,101 for 65 services; 2024 $7,910 for 97 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charlotte-Paige M Rolle prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 203 prescriptions and refills. In total Charlotte-Paige M Rolle wrote 1,053 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 203 | 203 | 22 | $800K |
| Pifeltro Doravirine | 72 | 80 | Under 11 | $131K |
| Tivicay Dolutegravir Sodium | 66 | 66 | Under 11 | $148K |
| Trogarzo Ibalizumab-Uiyk | 62 | 62 | Under 11 | $730K |
| Dovato Dolutegravir Sodium/Lamivudine | 46 | 46 | Under 11 | $138K |
| Rukobia Fostemsavir Tromethamine | 36 | 36 | Under 11 | $318K |
| Descovy Emtricitabine/Tenofov Alafenam | 29 | 29 | Under 11 | $64K |
| Ritonavir Generic | 26 | 28 | Under 11 | $3,882 |
| Cabenuva Cabotegravir/Rilpivirine | 23 | 44 | Under 11 | $151K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 21 | 21 | Under 11 | $82K |
| Darunavir Generic | 18 | 18 | Under 11 | $21K |
| Isentress Raltegravir Potassium | 18 | 18 | Under 11 | $37K |
| Ondansetron Hcl Generic | 16 | 16 | Under 11 | $242 |
| Valacyclovir Valacyclovir Hcl | 15 | 43 | Under 11 | $2,156 |
| Trazodone Hcl Generic | 15 | 21 | Under 11 | $125 |
Brand drugs: 677 claims; generic drugs: 376 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charlotte-Paige M Rolle $113K ($113K in general payments such as food, travel and fees) from 6 companies. The largest payer was ViiV Healthcare Company with $78K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.